vs
REDWOOD TRUST INC（RWT）与RECURSION PHARMACEUTICALS, INC.（RXRX）财务数据对比。点击上方公司名可切换其他公司
RECURSION PHARMACEUTICALS, INC.的季度营收约是REDWOOD TRUST INC的1.4倍（$35.5M vs $25.9M），REDWOOD TRUST INC净利率更高（77.2% vs -304.2%，领先381.5%），RECURSION PHARMACEUTICALS, INC.同比增速更快（681.7% vs -6.1%），过去两年RECURSION PHARMACEUTICALS, INC.的营收复合增速更高（60.5% vs -41.0%）
Redwood Trust Inc是总部位于美国的专业房地产投资信托公司，主营住宅与商业抵押贷款、抵押贷款支持证券及房地产信贷类资产的投资管理，核心业务覆盖住宅抵押贷款发放、商业地产信贷和投资服务，客户以机构投资者和房地产市场参与者为主。
Recursion Pharmaceuticals是一家临床阶段生物技术企业，依托人工智能技术和高通量生物实验体系，开发针对罕见病、肿瘤、炎症性疾病等领域未满足医疗需求的创新疗法，核心市场覆盖北美，与全球多家生物制药企业合作推进在研管线落地。
RWT vs RXRX — 直观对比
营收规模更大
RXRX
是对方的1.4倍
$25.9M
营收增速更快
RXRX
高出687.8%
-6.1%
净利率更高
RWT
高出381.5%
-304.2%
两年增速更快
RXRX
近两年复合增速
-41.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $25.9M | $35.5M |
| 净利润 | $20.0M | $-108.1M |
| 毛利率 | — | 59.8% |
| 营业利润率 | — | -304.8% |
| 净利率 | 77.2% | -304.2% |
| 营收同比 | -6.1% | 681.7% |
| 净利润同比 | 402.6% | 39.6% |
| 每股收益（稀释后） | $0.11 | $-0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收RWTRXRX
| Q4 25 | $25.9M | $35.5M | ||
| Q3 25 | $15.0M | $5.2M | ||
| Q2 25 | $13.8M | $19.2M | ||
| Q1 25 | $27.9M | $14.7M | ||
| Q4 24 | $27.6M | $4.5M | ||
| Q3 24 | $25.5M | $26.1M | ||
| Q2 24 | $67.4M | $14.4M | ||
| Q1 24 | $74.5M | $13.8M |
净利润RWTRXRX
| Q4 25 | $20.0M | $-108.1M | ||
| Q3 25 | $-7.7M | $-162.3M | ||
| Q2 25 | $-98.5M | $-171.9M | ||
| Q1 25 | $16.1M | $-202.5M | ||
| Q4 24 | $-6.6M | $-178.9M | ||
| Q3 24 | $14.8M | $-95.8M | ||
| Q2 24 | $15.5M | $-97.5M | ||
| Q1 24 | $30.3M | $-91.4M |
毛利率RWTRXRX
| Q4 25 | — | 59.8% | ||
| Q3 25 | — | -183.8% | ||
| Q2 25 | — | -4.9% | ||
| Q1 25 | — | -48.0% | ||
| Q4 24 | — | -181.4% | ||
| Q3 24 | — | 53.7% | ||
| Q2 24 | — | 36.2% | ||
| Q1 24 | — | 19.1% |
营业利润率RWTRXRX
| Q4 25 | — | -304.8% | ||
| Q3 25 | -9.0% | -3327.6% | ||
| Q2 25 | -679.0% | -916.8% | ||
| Q1 25 | 80.2% | -1297.9% | ||
| Q4 24 | -1.3% | -4042.4% | ||
| Q3 24 | 86.1% | -377.1% | ||
| Q2 24 | 30.3% | -697.4% | ||
| Q1 24 | 41.3% | -698.4% |
净利率RWTRXRX
| Q4 25 | 77.2% | -304.2% | ||
| Q3 25 | -51.4% | -3135.3% | ||
| Q2 25 | -712.0% | -894.2% | ||
| Q1 25 | 57.8% | -1373.3% | ||
| Q4 24 | -24.0% | -3935.5% | ||
| Q3 24 | 58.1% | -367.5% | ||
| Q2 24 | 23.0% | -676.6% | ||
| Q1 24 | 40.6% | -662.4% |
每股收益（稀释后）RWTRXRX
| Q4 25 | $0.11 | $-0.17 | ||
| Q3 25 | $-0.08 | $-0.36 | ||
| Q2 25 | $-0.76 | $-0.41 | ||
| Q1 25 | $0.10 | $-0.50 | ||
| Q4 24 | $-0.08 | $-0.56 | ||
| Q3 24 | $0.09 | $-0.34 | ||
| Q2 24 | $0.10 | $-0.40 | ||
| Q1 24 | $0.21 | $-0.39 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $255.7M | $743.3M |
| 总债务越低越好 | — | $9.6M |
| 股东权益账面价值 | $982.6M | $1.1B |
| 总资产 | $23.7B | $1.5B |
| 负债/权益比越低杠杆越低 | — | 0.01× |
8季度趋势，按日历期对齐
现金及短期投资RWTRXRX
| Q4 25 | $255.7M | $743.3M | ||
| Q3 25 | $226.3M | $659.8M | ||
| Q2 25 | $302.0M | $525.1M | ||
| Q1 25 | $259.9M | $500.5M | ||
| Q4 24 | $245.2M | $594.4M | ||
| Q3 24 | $253.7M | $427.6M | ||
| Q2 24 | $275.6M | $474.3M | ||
| Q1 24 | $275.4M | $296.3M |
总债务RWTRXRX
| Q4 25 | — | $9.6M | ||
| Q3 25 | — | $11.9M | ||
| Q2 25 | — | $14.2M | ||
| Q1 25 | — | $16.4M | ||
| Q4 24 | — | $19.0M | ||
| Q3 24 | — | $20.5M | ||
| Q2 24 | — | $22.9M | ||
| Q1 24 | $1.7B | — |
股东权益RWTRXRX
| Q4 25 | $982.6M | $1.1B | ||
| Q3 25 | $999.0M | $1.0B | ||
| Q2 25 | $1.1B | $919.1M | ||
| Q1 25 | $1.2B | $933.9M | ||
| Q4 24 | $1.2B | $1.0B | ||
| Q3 24 | $1.2B | $524.6M | ||
| Q2 24 | $1.2B | $584.4M | ||
| Q1 24 | $1.2B | $401.2M |
总资产RWTRXRX
| Q4 25 | $23.7B | $1.5B | ||
| Q3 25 | $22.6B | $1.4B | ||
| Q2 25 | $21.3B | $1.3B | ||
| Q1 25 | $19.9B | $1.3B | ||
| Q4 24 | $18.3B | $1.4B | ||
| Q3 24 | $18.4B | $726.5M | ||
| Q2 24 | $16.5B | $775.9M | ||
| Q1 24 | $15.1B | $557.8M |
负债/权益比RWTRXRX
| Q4 25 | — | 0.01× | ||
| Q3 25 | — | 0.01× | ||
| Q2 25 | — | 0.02× | ||
| Q1 25 | — | 0.02× | ||
| Q4 24 | — | 0.02× | ||
| Q3 24 | — | 0.04× | ||
| Q2 24 | — | 0.04× | ||
| Q1 24 | 1.39× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-10.1B | $-46.1M |
| 自由现金流经营现金流 - 资本支出 | — | $-47.3M |
| 自由现金流率自由现金流/营收 | — | -133.1% |
| 资本支出强度资本支出/营收 | — | 3.5% |
| 现金转化率经营现金流/净利润 | -504.15× | — |
| 过去12个月自由现金流最近4个季度 | — | $-378.3M |
8季度趋势，按日历期对齐
经营现金流RWTRXRX
| Q4 25 | $-10.1B | $-46.1M | ||
| Q3 25 | $-2.7B | $-117.4M | ||
| Q2 25 | $-2.1B | $-76.4M | ||
| Q1 25 | $-2.0B | $-132.0M | ||
| Q4 24 | $-5.9B | $-115.4M | ||
| Q3 24 | $-2.1B | $-59.2M | ||
| Q2 24 | $-2.0B | $-82.2M | ||
| Q1 24 | $-954.2M | $-102.3M |
自由现金流RWTRXRX
| Q4 25 | — | $-47.3M | ||
| Q3 25 | — | $-117.6M | ||
| Q2 25 | — | $-79.6M | ||
| Q1 25 | — | $-133.8M | ||
| Q4 24 | — | $-116.7M | ||
| Q3 24 | — | $-63.8M | ||
| Q2 24 | — | $-83.4M | ||
| Q1 24 | — | $-109.0M |
自由现金流率RWTRXRX
| Q4 25 | — | -133.1% | ||
| Q3 25 | — | -2272.5% | ||
| Q2 25 | — | -413.9% | ||
| Q1 25 | — | -907.4% | ||
| Q4 24 | — | -2567.7% | ||
| Q3 24 | — | -244.6% | ||
| Q2 24 | — | -578.5% | ||
| Q1 24 | — | -789.9% |
资本支出强度RWTRXRX
| Q4 25 | — | 3.5% | ||
| Q3 25 | — | 4.7% | ||
| Q2 25 | — | 16.4% | ||
| Q1 25 | — | 12.4% | ||
| Q4 24 | — | 28.6% | ||
| Q3 24 | — | 17.5% | ||
| Q2 24 | — | 8.2% | ||
| Q1 24 | — | 48.2% |
现金转化率RWTRXRX
| Q4 25 | -504.15× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | -120.92× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -140.86× | — | ||
| Q2 24 | -126.56× | — | ||
| Q1 24 | -31.53× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
